No Data
No Data
Only Three Days Left To Cash In On Tasly Pharmaceutical Group's (SHSE:600535) Dividend
Is Tasly Pharmaceutical Group (SHSE:600535) A Risky Investment?
Tasly Pharmaceutical Group (600535.SH) plans to distribute a dividend of 0.26 yuan per share for the half year, with ex-rights and ex-dividends on October 10th.
Tasly Pharmaceutical Group (600535.SH) announced that the company plans to distribute a cash dividend of 0.26 yuan per share for the first half of 2024...
Tasly Pharmaceutical Group's (600535.SH) subsidiary, Carter's oral solution of bupropion hydrochloride, has obtained a pharmaceutical registration certificate.
Tasly Pharmaceutical Group (600535.SH) announced that its wholly-owned subsidiary, Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., ...
Tasly Pharmaceutical Group Co., Ltd Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Tasly Pharmaceutical Group 2024 Semi-Annual Report
No Data
No Data